Shoji Kawauchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shoji Kawauchi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Sayo Horibe
Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
3 shared publications - Yoshiyuki Rikitake
Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
3 shared publications Junichi Kunimasa
Kobe Pharmaceutical University, Kobe, Japan
1 shared publicationNaoto Sasaki
Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University, Kobe, Japan
1 shared publication- Naoto Sasaki
Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University, Kobe, Japan
1 shared publication Sayo Horibe
Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University, Kobe, Japan
1 shared publication
Latest Publications
- Open Access
- 2 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Disruption of small intestinal mucosal homeostasis in mice with amiodarone induced steatohepatitis
In the current study, we sought to investigate the pathogenesis of amiodarone (AMD)-induced steatohepatitis, focusing on the pathological changes in the small intestine and liver. The association between patients taking AMD and metabolic dysfunction-associated steatohepatitis (MASH) was analyzed using the Japanese Adverse Drug Event Report (JADER) database. Barrier functions, such as crypt-villus architecture, mucosal permeability, and intestinal microbiota composition, were analyzed in a mouse model of AMD-induced steatohepatitis. The JADER database revealed positive signals for MASH in patients taking AMD. AMD induced lipid accumulation and inflammation, Tnf mRNA expression, and F4/80+CD14+ cell infiltration in the mouse liver. Villus shortening, changes in the localization of tight junction proteins, increased mucosal permeability, and altered intestinal microbiota were observed in the small intestines of AMD-treated mice. Moreover, the localization of leucine-rich repeat-containing G-protein coupled receptor (Lgr) 5+ and the Wnt/β-catenin signaling pathway was impaired in the small intestines of these mice. Lgr 5+ crypt base columnar stem cells, which are regulated by the Wnt/β-catenin signaling pathway, play an important role in intestinal mucosal homeostasis. Our data suggest that intestinal homeostasis is disrupted in AMD-induced MASH, which provides important insights into the development of therapeutic approaches for difficult-to-treat drug-induced MASH.
- 2 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Open AccessDisruption of small intestinal mucosal homeostasis in mice with amiodarone induced steatohepatitis
In the current study, we sought to investigate the pathogenesis of amiodarone (AMD)-induced steatohepatitis, focusing on the pathological changes in the small intestine and liver. The association between patients taking AMD and metabolic dysfunction-associated steatohepatitis (MASH) was analyzed using the Japanese Adverse Drug Event Report (JADER) database. Barrier functions, such as crypt-villus architecture, mucosal permeability, and intestinal microbiota composition, were analyzed in a mouse model of AMD-induced steatohepatitis. The JADER database revealed positive signals for MASH in patients taking AMD. AMD induced lipid accumulation and inflammation, Tnf mRNA expression, and F4/80+CD14+ cell infiltration in the mouse liver. Villus shortening, changes in the localization of tight junction proteins, increased mucosal permeability, and altered intestinal microbiota were observed in the small intestines of AMD-treated mice. Moreover, the localization of leucine-rich repeat-containing G-protein coupled receptor (Lgr) 5+ and the Wnt/β-catenin signaling pathway was impaired in the small intestines of these mice. Lgr 5+ crypt base columnar stem cells, which are regulated by the Wnt/β-catenin signaling pathway, play an important role in intestinal mucosal homeostasis. Our data suggest that intestinal homeostasis is disrupted in AMD-induced MASH, which provides important insights into the development of therapeutic approaches for difficult-to-treat drug-induced MASH.
- Open Access
- 9 February 2019
- Published by MDPI AG in Marine Drugs
- Vol. 17 (2) , 104
Inhibitory Effects of Sodium Alginate on Hepatic Steatosis in Mice Induced by a Methionine- and Choline-Deficient Diet
Nonalcoholic steatohepatitis (NASH) progresses from nonalcoholic fatty liver disease (NAFLD); however, efficacious drugs for NASH treatment are lacking. Sodium alginate (SA), a soluble dietary fiber extracted from brown algae, could protect the small intestine from enterobacterial invasion. NASH pathogenesis has been suggested to be associated with enterobacterial invasion, so we examined the effect of SA on methionine- and choline-deficient (MCD) diet-induced steatohepatitis in mice (the most widely-used model of NASH). The mice (n = 31) were divided into three groups (mice fed with regular chow, MCD diet, and MCD diet premixed with 5% SA) for 4 and 8 weeks. The MCD diet increased lipid accumulation and inflammation in the liver, the NAFLD Activity Score and hepatic mRNA expression of tumor necrosis factor-α and collagen 1α1, and induced macrophage infiltration. Villus shortening, disruption of zonula occludens-1 localization and depletion of mucus production were observed in the small intestine of the MCD-group mice. SA administration improved lipid accumulation and inflammation in the liver, and impaired barrier function in the small intestine. Collectively, these results suggest that SA is useful for NASH treatment because it can prevent hepatic inflammation and fatty degeneration by maintaining intestinal barrier function.
- 9 February 2019
- Published by MDPI AG in Marine Drugs
- Vol. 17 (2) , 104
Open AccessInhibitory Effects of Sodium Alginate on Hepatic Steatosis in Mice Induced by a Methionine- and Choline-Deficient Diet
Nonalcoholic steatohepatitis (NASH) progresses from nonalcoholic fatty liver disease (NAFLD); however, efficacious drugs for NASH treatment are lacking. Sodium alginate (SA), a soluble dietary fiber extracted from brown algae, could protect the small intestine from enterobacterial invasion. NASH pathogenesis has been suggested to be associated with enterobacterial invasion, so we examined the effect of SA on methionine- and choline-deficient (MCD) diet-induced steatohepatitis in mice (the most widely-used model of NASH). The mice (n = 31) were divided into three groups (mice fed with regular chow, MCD diet, and MCD diet premixed with 5% SA) for 4 and 8 weeks. The MCD diet increased lipid accumulation and inflammation in the liver, the NAFLD Activity Score and hepatic mRNA expression of tumor necrosis factor-α and collagen 1α1, and induced macrophage infiltration. Villus shortening, disruption of zonula occludens-1 localization and depletion of mucus production were observed in the small intestine of the MCD-group mice. SA administration improved lipid accumulation and inflammation in the liver, and impaired barrier function in the small intestine. Collectively, these results suggest that SA is useful for NASH treatment because it can prevent hepatic inflammation and fatty degeneration by maintaining intestinal barrier function.
- Open Access
- 6 January 2018
- Published by Springer Nature in BMC Cancer
- Vol. 18 (1) , 1-9
Mechanism of recipient cell-dependent differences in exosome uptake
Exosomes, small-membrane vesicles, are secreted by cells and include several types of proteins and nucleic acids. Exosomes transfer cellular information derived from donor cells and are involved in various physiological and pathological events, such as organ-specific metastasis. Elucidating the exosome uptake mechanisms is important for understanding the progression processes of organ-specific metastasis. However, whether the exosomes secreted by the donor cells are selectively or non-selectively incorporated into the recipient cells is unknown. In this study, three human carcinoma cell lines, A549 (lung), HCT116 and COLO205 (colon), were used. The exosome isolation efficiency was compared between three methods: ultracentrifugation, ExoQuick-TC and Total Exosome Isolation kits. Recipient cells were treated with Pitstop 2, an inhibitor of clathrin-dependent endocytosis, or genistein, an inhibitor of caveolae-dependent endocytosis, and then incubated with DiO-labeled exosomes. Among the three methods examined, ultracentrifugation was the most efficient and reproducible. Exosomes derived from a donor cell line are incorporated into the three cell lines, but the exosome uptake capability was different depending on the recipient cell type and did not depend on the donor cell type. Exosome uptake in COLO205 was inhibited by Pitstop 2 and genistein. Exosome uptake in HCT116 was inhibited by Pitstop 2, but not genistein, while that in A549 cells was not inhibited by these inhibitors. Taken together, these results suggest that the exosomes secreted by donor cells are non-selectively incorporated into recipient cells and that the exosome uptake mechanism is different depending on the recipient cells. Different recipient cells’ exosome uptake capabilities may be involved in organ-specific metastasis.
- 6 January 2018
- Published by Springer Nature in BMC Cancer
- Vol. 18 (1) , 1-9
Open AccessMechanism of recipient cell-dependent differences in exosome uptake
Exosomes, small-membrane vesicles, are secreted by cells and include several types of proteins and nucleic acids. Exosomes transfer cellular information derived from donor cells and are involved in various physiological and pathological events, such as organ-specific metastasis. Elucidating the exosome uptake mechanisms is important for understanding the progression processes of organ-specific metastasis. However, whether the exosomes secreted by the donor cells are selectively or non-selectively incorporated into the recipient cells is unknown. In this study, three human carcinoma cell lines, A549 (lung), HCT116 and COLO205 (colon), were used. The exosome isolation efficiency was compared between three methods: ultracentrifugation, ExoQuick-TC and Total Exosome Isolation kits. Recipient cells were treated with Pitstop 2, an inhibitor of clathrin-dependent endocytosis, or genistein, an inhibitor of caveolae-dependent endocytosis, and then incubated with DiO-labeled exosomes. Among the three methods examined, ultracentrifugation was the most efficient and reproducible. Exosomes derived from a donor cell line are incorporated into the three cell lines, but the exosome uptake capability was different depending on the recipient cell type and did not depend on the donor cell type. Exosome uptake in COLO205 was inhibited by Pitstop 2 and genistein. Exosome uptake in HCT116 was inhibited by Pitstop 2, but not genistein, while that in A549 cells was not inhibited by these inhibitors. Taken together, these results suggest that the exosomes secreted by donor cells are non-selectively incorporated into recipient cells and that the exosome uptake mechanism is different depending on the recipient cells. Different recipient cells’ exosome uptake capabilities may be involved in organ-specific metastasis.
- 14 October 2016
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 37 (9) , 522-532
Down-regulation of hepatic CYP3A1 expression in a rat model of indomethacin-induced small intestinal ulcers
- 14 October 2016
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 37 (9) , 522-532
Down-regulation of hepatic CYP3A1 expression in a rat model of indomethacin-induced small intestinal ulcers